Literature DB >> 31996992

cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas.

Daniel J Brat1, Kenneth Aldape2, Howard Colman3, Dominique Figrarella-Branger4, Gregory N Fuller5, Caterina Giannini6, Eric C Holland7, Robert B Jenkins6, Bette Kleinschmidt-DeMasters8, Takashi Komori9, Johan M Kros10, David N Louis11, Catriona McLean12, Arie Perry13, Guido Reifenberger14,15, Chitra Sarkar16, Roger Stupp17, Martin J van den Bent18, Andreas von Deimling19,20, Michael Weller21.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31996992     DOI： 10.1007/s00401-020-02127-9

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  103 in total

Review 1.  Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Authors:  Patrick Y Wen; Michael Weller; Eudocia Quant Lee; Brian M Alexander; Jill S Barnholtz-Sloan; Floris P Barthel; Tracy T Batchelor; Ranjit S Bindra; Susan M Chang; E Antonio Chiocca; Timothy F Cloughesy; John F DeGroot; Evanthia Galanis; Mark R Gilbert; Monika E Hegi; Craig Horbinski; Raymond Y Huang; Andrew B Lassman; Emilie Le Rhun; Michael Lim; Minesh P Mehta; Ingo K Mellinghoff; Giuseppe Minniti; David Nathanson; Michael Platten; Matthias Preusser; Patrick Roth; Marc Sanson; David Schiff; Susan C Short; Martin J B Taphoorn; Joerg-Christian Tonn; Jonathan Tsang; Roel G W Verhaak; Andreas von Deimling; Wolfgang Wick; Gelareh Zadeh; David A Reardon; Kenneth D Aldape; Martin J van den Bent
Journal:  Neuro Oncol       Date:  2020-08-17       Impact factor: 12.300

Review 2.  The cIMPACT-NOW updates and their significance to current neuro-oncology practice.

Authors:  L Nicolas Gonzalez Castro; Pieter Wesseling
Journal:  Neurooncol Pract       Date:  2020-08-29

3.  Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2A homozygous deletion in the assessment of adult-type infiltrating astrocytoma.

Authors:  Kaishi Satomi; Makoto Ohno; Yuko Matsushita; Masamichi Takahashi; Yasuji Miyakita; Yoshitaka Narita; Koichi Ichimura; Akihiko Yoshida
Journal:  Mod Pathol       Date:  2020-10-19       Impact factor: 7.842

4.  IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification.

Authors:  Giulia Berzero; Anna Luisa Di Stefano; Susanna Ronchi; Franck Bielle; Chiara Villa; Erell Guillerm; Laurent Capelle; Bertrand Mathon; Alice Laurenge; Marine Giry; Yohann Schmitt; Yannick Marie; Ahmed Idbaih; Khe Hoang-Xuan; Jean-Yves Delattre; Karima Mokhtari; Marc Sanson
Journal:  Neuro Oncol       Date:  2021-06-01       Impact factor: 12.300

5.  Is Next-Generation Sequencing Alone Sufficient to Reliably Diagnose Gliomas?

Authors:  Kwok Ling Kam; Christina L Appin; Qinwen Mao; Sachie Ikegami; Rimas V Lukas; Marina N Nikiforova; Somak Roy; Daniel J Brat; Craig Horbinski
Journal:  J Neuropathol Exp Neurol       Date:  2020-07-01       Impact factor: 3.685

6.  Clinical implications of molecular analysis in diffuse glioma stratification.

Authors:  Masahiro Mizoguchi; Nobuhiro Hata; Daisuke Kuga; Ryusuke Hatae; Yojiro Akagi; Yuhei Sangatsuda; Yutaka Fujioka; Kosuke Takigawa; Yusuke Funakoshi; Satoshi O Suzuki; Toru Iwaki
Journal:  Brain Tumor Pathol       Date:  2021-07-15       Impact factor: 3.298

Review 7.  Extent of Resection of Glioblastoma: A Critical Evaluation in the Molecular Era.

Authors:  Daniel P Cahill
Journal:  Neurosurg Clin N Am       Date:  2020-11-05       Impact factor: 2.509

8.  Checkpoint inhibitor immunotherapy for glioblastoma: current progress, challenges and future outlook.

Authors:  Patrick C Gedeon; Cosette D Champion; Kristen E Rhodin; Karolina Woroniecka; Hanna R Kemeny; Alexa N Bramall; Joshua D Bernstock; Bryan D Choi; John H Sampson
Journal:  Expert Rev Clin Pharmacol       Date:  2020-09-11       Impact factor: 5.045

Review 9.  The immune landscape of common CNS malignancies: implications for immunotherapy.

Authors:  Martina Ott; Robert M Prins; Amy B Heimberger
Journal:  Nat Rev Clin Oncol       Date:  2021-06-11       Impact factor: 66.675

10.  TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma.

Authors:  Kenji Fujimoto; Hideyuki Arita; Kaishi Satomi; Kai Yamasaki; Yuko Matsushita; Taishi Nakamura; Yasuji Miyakita; Toru Umehara; Keiichi Kobayashi; Kaoru Tamura; Shota Tanaka; Fumi Higuchi; Yoshiko Okita; Yonehiro Kanemura; Junya Fukai; Daisuke Sakamoto; Takehiro Uda; Ryunosuke Machida; Aya Kuchiba; Taketoshi Maehara; Motoo Nagane; Ryo Nishikawa; Hiroyoshi Suzuki; Makoto Shibuya; Takashi Komori; Yoshitaka Narita; Koichi Ichimura
Journal:  Acta Neuropathol       Date:  2021-06-20       Impact factor: 17.088
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.